Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract

Human Pathology

Volumn 44, Issue 2, 2013, Pages 164-172

  Gulmann, Christian ^a   Paner, Gladell P ^b   Parakh, Rugvedita S ^c   Hansel, Donna E ^d   Shen, Steven S ^e   Ro, Jae Y ^e   Annaiah, Chandrakanth ^c   Lopez Beltran, Antonio ^f   Rao, Priya ^g   Arora, Komal ^c   Cho, Yong ^h   Herrera Hernandez, Loren ^c   Alsabeh, Randa ^c   Amin, Mahul B ^c  

^a BEAUMONT HOSPITAL   (Ireland)

^b UNIVERSITY OF CHICAGO   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d TAUSSIG CANCER INSTITUTE   (United States)

^e HOUSTON METHODIST HOSPITAL   (United States)

^f UNIVERSITY OF CÓRDOBA   (Spain)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h University of Ulsan College of Medicine   (South Korea)

Author keywords

Cytokeratin 14; Desmoglein 3; GATA3; S100P; Squamous cell carcinoma; Uroplakin III; Urothelial carcinoma

Indexed keywords

CYTOKERATIN 14; DESMOGLEIN 3; PROTEIN; PROTEIN ANTIBODY; S100P PROTEIN; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG; UROPLAKIN 3;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINIZATION; MALE; PROTEIN EXPRESSION; PURE SQUAMOUS CELL CARCINOMA; PURE UROTHELIAL CARCINOMA; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; TUMOR DIFFERENTIATION; UROGENITAL TRACT CANCER; UROTHELIAL CARCINOMA WITH SQUAMOUS DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; CALCIUM-BINDING PROTEINS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; DESMOGLEIN 3; DIAGNOSIS, DIFFERENTIAL; FEMALE; GATA3 TRANSCRIPTION FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-14; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM PROTEINS; PELVIC NEOPLASMS; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UROLOGIC NEOPLASMS; UROPLAKIN III; UROTHELIUM;

EID: 84872683637     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.05.018     Document Type: Article

References (35)

1. D.S. Kaufman, W.U. Shipley, and A.S. Feldman Bladder cancer Lancet 374 2009 239 248
2. M.B. Amin Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications Mod Pathol 22 2009 S96 S118
3. P.C. Black, G.A. Brown, and C.P.N. Dinney The impact of variant histology on the outcome of bladder cancer treated with curative intent Urol Oncol 27 2009 3 7
4. A. Lopez-Beltran, and L. Cheng Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications Hum Pathol 37 2006 1371 1388 (Pubitemid 44584326)
5. J.E. Martin, B.J. Jenkins, R.J. Zuk, J.P. Blandy, and S.I. Baithun Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder J Clin Pathol 42 1989 250 253 (Pubitemid 19077266)
6. P. Dahm, and J.E. Gschwend Malignant non-urothelial neoplasms of the urinary bladder: a review Eur Urol 44 2003 672 681 (Pubitemid 37542925)
7. W. Kassouf, P.E. Spiess, and A. Siefker-Radtke Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience Cancer 110 2007 764 769 (Pubitemid 47257652)
8. M. Ploeg, K.K. Aben, C.A. Hulsbergen-van de Kaa, M.P. Schoenberg, J.A. Witjes, and L.A. Kiemeney Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands Cancer Registry J Urol 183 2010 915 920
9. J.S. Rundle, A.J. Hart, A. McGeorge, J.S. Smith, A.J. Malcom, and P.M. Smith Squamous cell carcinoma of bladder. A review of 114 patients Br J Urol 54 1982 522 526 (Pubitemid 13204329)
10. H. Abol-Enein, B.R. Kava, and A.J.K. Carmack Non-urothelial cancer of the bladder Urology 69 1 suppl 2007 93 104
11. A. Akdas, and L. Turkeri The impact of squamous metaplasia in transitional cell carcinoma of the bladder Int Urol Nephrol 23 1991 333 336
12. M.A. Ghonheim, M.M. el-Mekresh, M.A. el-Baz, I.A. el-Attar, and A. Ashamallah Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases J Urol 158 1997 393 399 (Pubitemid 27327674)
13. I. Honma, N. Masumori, and E. Sato Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors Urology 64 2004 744 748 (Pubitemid 39446055)
14. N. Lagwinski, A. Thomas, and A.J. Stephenson Squamous cell carcinoma of the bladder: a clinicopathological analysis of 45 cases Am J Surg Pathol 31 2007 1777 1787 (Pubitemid 350175805)
15. C.G. Rogers, G.S. Palapattu, and S.F. Shariat Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder J Urol 175 2006 2048 2053 (Pubitemid 43668580)
16. M.J. Wasco, S. Daignault, and Y. Zhang Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection Urology 70 2007 69 74 (Pubitemid 47081105)
17. Q.J. Zhai, J. Black, A.G. Ayala, and J.Y. Ro Histologic variants of infiltrating urothelial carcinoma Arch Pathol Lab Med 131 2007 1244 1256 (Pubitemid 47257637)
18. L. Cheng, A. Lopez-Beltran, G.T. MacLennan, R. Montironi, and D.G. Bostwick Neoplasms of the urinary bladder D.G. Bostwick, L. Cheng, Urologic Surgical Pathology 2nd ed. 2008 Mosby Philadelphia, PA 259 351
19. J. Eble, J. Epstein, G. Sauter, J.I. Epstein, and I.A. Sesterhenn World Health Organization classification of tumors, pathology and genetics of tumors of the urinary system and male genital organs 2004 IARC Press Lyon, France
20. McKenny JK. Invasive squamous cell carcinoma. In: Amin MA, McKenny JK, Tickoo SK, et al., eds. Diagnostic Pathology. Genitourinary. Philadelphia, PA: Lippincott Williams & Wilkins; 2010. p. 152-7
21. N.T. Gaisa, T. Braunschweig, and N. Reimer Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer Virchows Arch 458 2011 301 312
22. NCCN® Clinical Practice Guidelines in Oncology. Bladder Cancer. 2009 [National Comprehensive Cancer Networks website]. 2009. www.nccn.org/ professionals/physician-gls/PDF/bladder.pdf.
23. M.K. Fuentes, S.S. Nigavekar, and T. Arumugam RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways Dis Colon Rectum 50 2007 1230 1240 (Pubitemid 47087458)
24. J.P. Higgins, G. Kaygusuz, and L. Wang Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray Am J Surg Pathol 31 2007 673 680 (Pubitemid 46684205)
25. A.Y. Chuang, A.M. DeMarzo, R.W. Veltri, R.B. Sharma, C.J. Bieberich, and J.I. Epstein Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma Am J Surg Pathol 31 2007 1246 1255 (Pubitemid 47207130)
26. J. Chou, S. Provot, and Z. Werb GATA3 in development and cancer differentiation: cells GATA have it! Cell Physiol. 222 2010 42 49
27. C.D. Savci-Heijink, F. Kosari, and M.C. Aubry The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung Am J Pathol 174 2009 1629 1637
28. P.G. Chu, M.H. Lyda, and L.M. Weiss Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours Histopathology 39 2001 9 16 (Pubitemid 32848269)
29. P. Harnden, and J. Southgate Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas J Clin Pathol 50 1997 1032 1033 (Pubitemid 28055633)
30. S. Vaidyanathan, I.W. McDicken, and P. Mansour Detection of early squamous metaplasia in bladder biopsies of spinal cord injury patients by immunostaining for cytokeratin 14 Spinal Cord 41 2003 432 434 (Pubitemid 36976463)
31. D.C. Parker, A.L. Folpe, and J. Bell Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas Am J Surg Pathol 27 2003 1 10 (Pubitemid 36014893)
32. Y. Ohtsuka, S. Kawakami, and Y. Fujii Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract BJU Int 97 2006 1322 1326 (Pubitemid 43907343)
33. A. Fong, E. Garcia, L. Gwynn, M.P. Lisanti, M.J. Fazzari, and M. Li Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation Am J Clin Pathol 120 2003 93 100 (Pubitemid 37046375)
34. A. Lopez-Beltran, M.J. Requena, J. Alvarez-Kindelan, A. Quintero, A. Blanca, and R. Montironi Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry J Clin Pathol 60 2007 332 335 (Pubitemid 46447757)
35. J.E. Celis, P. Celis, and M. Ostergaard Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions Cancer Res 59 1999 3003 3009 (Pubitemid 29283144)